A.R. Pachner

Neutralizing anti-IFNß antibodies: clarity and confusion
Mult Scler 2007 13: 1081-1082. [PDF] [References]  

S. Amor and G. Giovannoni

Antibodies to myelin oligodendrocyte glycoprotein as a biomarker in multiple sclerosis — are we there yet?
Mult Scler 2007 13: 1083-1085. [PDF] [References]  

V. Tomassini, L. De Giglio, M. Reindl, P. Russo, I. Pestalozza, P. Pantano, T. Berger, and C. Pozzilli

Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS
Mult Scler 2007 13: 1086-1094. [Abstract] [PDF] [References]  

A.I. Bhigjee, K. Moodley, and K. Ramkissoon

Multiple sclerosis in KwaZulu Natal, South Africa: an epidemiological and clinical study
Mult Scler 2007 13: 1095-1099. [Abstract] [PDF] [References]  

R. Höftberger, F. Garzuly, H.P. Dienes, J. Grubits, B. Rohonyi, G. Fischer, Z. Hanzely, H. Lassmann, and H. Budka

Fulminant central nervous system demyelination associated with interferon- therapy and hepatitis C virus infection
Mult Scler 2007 13: 1100-1106. [Abstract] [PDF] [References]  

D. Pöhlau, H. Przuntek, M. Sailer, F. Bethke, J. Koehler, N. König, C. Heesen, P. Späth, and I. Andresen

Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis: a randomized placebo controlled multicentre study
Mult Scler 2007 13: 1107-1117. [Abstract] [PDF] [References]  

K.M. Mitchell, A.L. Dotson, K.M. Cool, A. Chakrabarty, S.H. Benedict, and S.M. LeVine

Deferiprone, an orally deliverable iron chelator, ameliorates experimental autoimmune encephalomyelitis
Mult Scler 2007 13: 1118-1126. [Abstract] [PDF] [References]  

C. Boz, J. Oger, E. Gibbs, and S.E. Grossberg the Neurologists of the UBC MS Clinic

Reduced effectiveness of long-term interferon-ß treatment on relapses in neutralizing antibody-positive multiple sclerosis patients: a Canadian multiple sclerosis clinic-based study
Mult Scler 2007 13: 1127-1137. [Abstract] [PDF] [References]  

T. Kümpfel, M. Schwan, Th. Pollmächer, A. Yassouridis, M. Uhr, C. Trenkwalder, and F. Weber

Time of interferon-ß 1a injection and duration of treatment affect clinical side effects and acute changes of plasma hormone and cytokine levels in multiple sclerosis patients
Mult Scler 2007 13: 1138-1145. [Abstract] [PDF] [References]  

A.P. Turner, D.R. Kivlahan, A.P. Sloan, and J.K. Haselkorn

Predicting ongoing adherence to disease modifying therapies in multiple sclerosis: utility of the health beliefs model
Mult Scler 2007 13: 1146-1152. [Abstract] [PDF] [References]  

K. Baum, C. O'Leary, F. Coret Ferrer, E. Klimova, L. Prochazkova, and J. Bugge for the BRIGHT Study Group

Comparison of injection site pain and injection site reactions in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a or 1b
Mult Scler 2007 13: 1153-1160. [Abstract] [PDF] [References]  

I.-K. Penner, N. Bechtel, C. Raselli, M. Stöcklin, K. Opwis, L. Kappos, and P. Calabrese

Fatigue in multiple sclerosis: relation to depression, physical impairment, personality and action control
Mult Scler 2007 13: 1161-1167. [Abstract] [PDF] [References]  

E.W. Peterson, C.C. Cho, and M.L. Finlayson

Fear of falling and associated activity curtailment among middle aged and older adults with multiple sclerosis
Mult Scler 2007 13: 1168-1175. [Abstract] [PDF] [References]  

R.A. Marrie and M. Goldman

Validity of performance scales for disability assessment in multiple sclerosis
Mult Scler 2007 13: 1176-1182. [Abstract] [PDF] [References]  

J. Sweetland, A. Riazi, S.J. Cano, and E.D. Playford

Vocational rehabilitation services for people with multiple sclerosis: what patients want from clinicians and employers
Mult Scler 2007 13: 1183-1189. [Abstract] [PDF] [References]  

E. Tripoliti, C. Campbell, T. Pring, and S. Taylor-Goh

Quality of life in multiple sclerosis: should clinicians trust proxy ratings?
Mult Scler 2007 13: 1190-1194. [Abstract] [PDF] [References]  

H.C. Lehmann, H.-P. Hartung, and B.C. Kieseier

Leopold Ordenstein: on paralysis agitans and multiple sclerosis
Mult Scler 2007 13: 1195-1199. [Abstract] [PDF] [References]  

F. Marrosu, A. Maleci, E. Cocco, M. Puligheddu, L. Barberini, and M.G. Marrosu

Vagal nerve stimulation improves cerebellar tremor and dysphagia in multiple sclerosis
Mult Scler 2007 13: 1200-1202. [Abstract] [PDF] [References]  

D. Koontz and A. Alshekhlee

Letter to the Editor: Embolia cutis medicamentosa following interferon beta injection
Mult Scler 2007 13: 1203-1204. [PDF] [References]  

'ACTRIMS ABSTRACTS: EMERGING THERAPIES IN MULTIPLE SCLEROSIS Basic and Clinical Issues in Multiple Sclerosis Research ACTRIMS ? 12th annual meeting, June 2, 2007 Washington, DC'
Mult Scler 2007 13: 1205-1244. [PDF]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.